Re: Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Fukuokaya W, Egawa S. Eur Urol 2021;79:553-554.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fukuokaya W, Egawa S. Re: Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2021;79:553-554.
PMID: 33277082